Everest Medicines Reveals Interim Study Outcomes
Everest Medicines, a leading biopharmaceutical company, has announced that it will provide a business update on August 29, 2025. The update will include the interim results for the six months ended June 30, 2025.
The company has not yet publicly released the detailed content of these interim results or the accompanying business update. However, they have announced that they will report these results and provide a business update via live conference calls in English and Mandarin.
The conference calls are scheduled as follows: - English session: 8:00 AM Beijing Time (8:00 PM U.S. Eastern Time Aug 28, 2025) - Mandarin session: 9:30 AM Beijing Time (9:30 PM U.S. Eastern Time Aug 28, 2025)
Participants can join the English session by dialing 1-646-2543594 or 852-30051313 (for Hong Kong, China) or 44-12-13680466 (for the United Kingdom, International). For the Mandarin session, participants can dial 86-10-58084199 (for Chinese Mainland) or 852-30051355 (for Hong Kong, China, Taiwan, China, and Singapore) or 852-300513550800-666-425 (for dial-in from Hong Kong, China).
The webcast link for the English session is https://www.acecamptech.com/meeting_live/70527911/811717?event_id=60525881. The Mandarin session does not have a publicly available webcast link at this time.
After the conference calls, the replay of the English session will be available on the Company's website at http://www.everestmedicines.com. The Mandarin session replay can be accessed by dialing 852-300513550800-666-425.
The upcoming event is expected to cover Everest Medicines' financial performance, clinical program progress, commercial updates, and strategic outlook. However, as of now, no substantive content of these updates is publicly available.
It is important to note that the interim results and business update from Everest Medicines are independent of any updates from other companies, such as Kezar Life Sciences.
In summary, Everest Medicines will release its interim results and provide a business update on August 29, 2025. The updates will be shared via live conference calls, with the English session scheduled for 8:00 AM Beijing Time and the Mandarin session for 9:30 AM Beijing Time. Participants can join the English session by dialing the provided numbers or accessing the webcast link, while the Mandarin session does not have a publicly available webcast link. After the conference calls, the replay of the English session will be available on the Company's website.
The upcoming business update from Everest Medicines on August 29, 2025, will include details about their financial performance and strategic outlook, providing insights into the company's ongoing business operations. After the live conference calls, the replay of the English session will be accessible on Everest Medicines' website, allowing interested parties to review the discussions at their convenience.
